Valuation: Galderma Group AG

Capitalization 2.42TCr 2.31TCr 2.14TCr 1.9TCr 3.42TCr 2,05100Cr 3.8TCr 27TCr 9.84TCr 84TCr 9.09TCr 8.88TCr 3,68800Cr P/E ratio 2024 *
126x
P/E ratio 2025 * 51.4x
Enterprise value 2.65TCr 2.52TCr 2.34TCr 2.08TCr 3.74TCr 2,24500Cr 4.16TCr 29TCr 11TCr 92TCr 9.95TCr 9.73TCr 4,03700Cr EV / Sales 2024 *
5.96x
EV / Sales 2025 * 5.22x
Free-Float
-
Yield 2024 *
0.08%
Yield 2025 * 0.3%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.44%
1 week+0.84%
Current month-0.07%
1 month+6.42%
3 months+11.90%
6 months+23.55%
More quotes
1 week
87.05
Extreme 87.05
90.65
1 month
82.50
Extreme 82.5
90.65
Current year
60.00
Extreme 60
90.65
1 year
60.00
Extreme 60
90.65
3 years
60.00
Extreme 60
90.65
5 years
60.00
Extreme 60
90.65
10 years
60.00
Extreme 60
90.65
More quotes
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.43%+0.84% - - 2.42TCr
-1.09%+2.48%-23.06%-18.30%19TCr
+1.51%+0.48%+15.64%+10.60%2.01TCr
-0.69%+5.26%-26.30%-58.53%739.01Cr
-1.10%+0.01%-34.88%-20.59%674.17Cr
+1.66%+3.16%-7.96%-10.84%506.61Cr
+4.12%+1.46%-11.40%-37.93%459.86Cr
+0.60%-0.22%+4.44%+48.26%443.4Cr
+4.85%-0.21%-16.34%-44.26%330.53Cr
+0.73%+3.65%-10.43%-21.32%326.32Cr
Average +1.10%+2.84%-12.26%-16.99% 2.73TCr
Weighted average by Cap. -0.49%+3.83%-19.09%-16.64%
See all sector performances

Financials

2024 *2025 *
Net sales 444.37Cr 423.8Cr 392.96Cr 348.58Cr 628.35Cr 38TCr 697.98Cr 4.88TCr 1.81TCr 15TCr 1.67TCr 1.63TCr 68TCr 498.35Cr 475.28Cr 440.7Cr 390.92Cr 704.68Cr 42TCr 782.77Cr 5.47TCr 2.03TCr 17TCr 1.87TCr 1.83TCr 76TCr
Net income 23Cr 22Cr 20Cr 18Cr 32Cr 1.92TCr 35Cr 248.14Cr 92Cr 787.56Cr 85Cr 83Cr 3.44TCr 49Cr 47Cr 44Cr 39Cr 70Cr 4.18TCr 78Cr 542.15Cr 200.76Cr 1.72TCr 185.39Cr 181.29Cr 7.53TCr
Net Debt 228.83Cr 218.24Cr 202.36Cr 179.5Cr 323.58Cr 19TCr 359.43Cr 2.51TCr 930.87Cr 7.98TCr 859.64Cr 840.6Cr 35TCr 181.6Cr 173.19Cr 160.59Cr 142.45Cr 256.79Cr 15TCr 285.24Cr 2TCr 738.74Cr 6.33TCr 682.21Cr 667.1Cr 28TCr
More financial data * Estimated data
Logo Galderma Group AG
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Employees
6,545
More about the company
Date Price Change Volume
11/24/11 90.19 CHF +0.43% 239,390
10/24/10 89.80 CHF +1.00% 295,779
09/24/09 88.91 CHF +1.30% 216,557
06/24/06 87.77 CHF -2.00% 212,044
05/24/05 89.56 CHF +0.13% 157,093

Delayed Quote Swiss Exchange, December 11, 2024 at 10:01 pm IST

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
101.81USD
Average target price
108.65USD
Spread / Average Target
+6.72%
Consensus

Quarterly revenue - Rate of surprise